Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of $125.41 million. The enterprise value is -$75.00 million.

Market Cap	125.41M
Enterprise Value	-75.00M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, after market close.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 66.01 million shares outstanding.

Shares Outstanding	66.01M
Owned by Insiders (%)	9.38%
Owned by Institutions (%)	14.70%
Float	43.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.34
Forward PS	1.93
PB Ratio	1.29
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.63, with a Debt / Equity ratio of 1.29.

Current Ratio	1.63
Quick Ratio	2.16
Debt / Equity	1.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.69

Financial Efficiency

Return on equity (ROE) is -75.10% and return on invested capital (ROIC) is -45.70%.

Return on Equity (ROE)	-75.10%
Return on Assets (ROA)	-23.20%
Return on Capital (ROIC)	-45.70%
Revenue Per Employee	$56,167
Profits Per Employee	-$302,509
Employee Count	216
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, Cellectis has paid $117,164 in taxes.

Income Tax	117,164
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.90% in the last 52 weeks. The beta is 3.09, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	3.09
52-Week Price Change	-6.90%
50-Day Moving Average	2.59
200-Day Moving Average	2.53
Relative Strength Index (RSI)	26.46
Average Volume (20 Days)	60,461

Short Selling Information

Short Interest	418,149
Short Previous Month	424,163
Short % of Shares Out	4.09%
Short % of Float	n/a
Short Ratio (days to cover)	12.97

Income Statement

In the last 12 months, Cellectis had revenue of $12.13 million and -$65.34 million in losses. Loss per share was -$1.44.

Revenue	12.13M
Gross Profit	12.61M
Operating Income	-101.86M
Pretax Income	-70.12M
Net Income	-65.34M
EBITDA	-8.59M
EBIT	-28.63M
Loss Per Share	-$1.44

Full Income Statement

Balance Sheet

The company has $325.94 million in cash and $125.53 million in debt, giving a net cash position of $200.41 million or $3.04 per share.

Cash & Cash Equivalents	325.94M
Total Debt	125.53M
Net Cash	200.41M
Net Cash Per Share	$3.04
Equity (Book Value)	97.35M
Book Value Per Share	1.47
Working Capital	107.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.21 million and capital expenditures -$1.16 million, giving a free cash flow of -$22.37 million.

Operating Cash Flow	-21.21M
Capital Expenditures	-1.16M
Free Cash Flow	-22.37M
FCF Per Share	-$0.31

Full Cash Flow Statement

Margins

Gross margin is 103.92%, with operating and profit margins of -839.63% and -538.59%.

Gross Margin	103.92%
Operating Margin	-839.63%
Pretax Margin	-577.97%
Profit Margin	-538.59%
EBITDA Margin	-70.84%
EBIT Margin	-235.96%
FCF Margin	-184.40%

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.57%
Shareholder Yield	-39.57%
Earnings Yield	-52.10%
FCF Yield	-17.84%

Analyst Forecast

The average price target for Cellectis is $8.00, which is 323.28% higher than the current price. The consensus rating is "Buy".

Price Target	$8.00
Price Target Difference	323.28%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	67.60%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -1.19 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.19
Piotroski F-Score	2